ITC Begins Another Section 337 Investigation on Hydrodermabrasion Systems
The International Trade Commission is beginning a Section 337 investigation into allegations from HydraFacial that seven companies are importing hydrodermabrasion systems that infringe on its patents, the ITC said in a notice Sept. 10. In a complaint filed in August…
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
(see 2408080008), subsequently amended, HydraFacial said Sinclair Pharma’s U.S. and U.K. branches, as well as Huadong Medicine, EMA Aesthetics, Aesthetics Management Partners, Advanced Aesthetics Services and H.R. Meditech, are infringing on patents related to HydraFacial’s systems for skin treatment through mechanical or fluid-based abrasion or exfoliation. The ITC will consider whether to issue a limited exclusion order and cease and desist orders against the seven companies.